ARCHIVES

HER2+ Tumors Increase Risk Of Recurrence, Study Finds

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | November 27, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: BRI Gets New FCRF Basic Research Contract; Senate Subcommittee Less Generous Than House

October 2, 1987

NCI audit Verifies Accuracy Of NSABP’s Lumpectomy Trial, B-06; Finds No Evidence Of Misrepresentation

October 21, 1994

In the States: Michigan to Allocate $50 Million Annually To Life Sciences

July 23, 1999

ACCC Annual Meeting Expands to 4 Days, One On Cancer Control

January 15, 1982

Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial

July 4, 2014

NCI Unveils Checklist for Omics Studies

February 7, 2013